AptarGroup, Inc. (ATR) Financials
ATR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 5.1 billion | 2.5 billion |
| June 30, 2026 | 5.1 billion | 2.5 billion |
| March 31, 2026 | 5.1 billion | 2.4 billion |
| Dec. 31, 2025 | 5.3 billion | 2.5 billion |
ATR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 98.6 million | 9.0 million |
| June 30, 2026 | 45.9 million | 7.0 million |
| March 31, 2026 | 53.3 million | 16.8 million |
| Dec. 31, 2025 | 96.9 million | 7.2 million |
ATR Net Income
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | 32.8 million |
| June 30, 2026 | 32.9 million |
| March 31, 2026 | 72.8 million |
| Dec. 31, 2025 | 74.3 million |
ATR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 212.3 million | 1.0 billion | 42.9 million |
| June 30, 2026 | 197.3 million | 1.1 billion | 43.9 million |
| March 31, 2026 | 229.5 million | 1.1 billion | 44.0 million |
| Dec. 31, 2025 | 409.5 million | 1.1 billion | 47.9 million |
ATR Shares Outstanding
ATR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 69.0 million | 160.2 million | 160.2 million | - |
| June 30, 2026 | 57.6 million | 157.7 million | 167.6 million | - |
| March 31, 2026 | 65.4 million | 167.6 million | 167.6 million | - |
| Dec. 31, 2025 | 86.8 million | 151.3 million | 151.0 million | - |
ATR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 1.0 billion | 721.7 million |
| June 30, 2026 | 1.0 billion | 740.6 million |
| March 31, 2026 | 982.9 million | 706.7 million |
| Dec. 31, 2025 | 962.7 million | 701.1 million |
ATR Revenue by Segment
ATR
List: Champions
Price: $141.57
Dividend Yield: 1.35%
Forward Dividend Yield: 1.41%
Payout Ratio: 37.82%
Dividend Per Share: 2.00 USD
Earnings Per Share: 4.27 USD
P/E Ratio: 34.39
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 284100
Ebitda: 129.6 millionMarket Capitalization: 9.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 34
DGR3: 6.40%
DGR5: 4.94%
DGR10: 4.87%
DGR20: 8.77%